Skip to main content
VNRX logo

VNRX · Volitionrx Ltd

Track VNRX — free
$0.54 -0.09 (-14.78%) At close · Aug 14
Market Cap
$7.34M
Shares
13.65M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019
Executive Total
Cameron Reynolds $517,691
Dr. Jason Terrell $436,135
David Vanston $316,792
Fiscal 2018
Executive Total
Cameron Reynolds $659,509
David Vanston $423,162
Dr. Jason Terrell $392,187

Executive changes

Person Change Filed
Dr. Salvatore Thomas Butera Terminated 2025-12-11
Timothy I. Still Appointed 2024-11-06
Timothy I. Still Appointed 2024-11-06
Dr. Ethel Rubin Appointed 2024-09-30
Cameron Reynolds Appointed 2024-07-03
Kim Nguyen Appointed 2024-07-03
Mickie Henshall Appointed 2024-07-03
Guy Innes Appointed 2024-07-03
Dr. Alan Colman Appointed 2024-07-03
Dr. Phillip Barnes Appointed 2024-07-03
Guy Innes Appointed 2024-04-26
Guy Innes Appointed 2024-04-26
Martin Faulkes Retired 2024-04-26
Edward Futcher Retired 2024-04-26
Martin Faulkes Retired 2024-04-26
Cameron Reynolds Appointed 2023-06-30
Kim Nguyen Appointed 2023-06-30
Guy Innes Appointed 2023-06-30
Dr. Edward Futcher Appointed 2023-06-30
Mickie Henshall Appointed 2023-06-30
Dr. Martin Faulkes Appointed 2023-06-30
Dr. Alan Colman Appointed 2023-06-30
Dr. Phillip Barnes Appointed 2023-06-30
Dr. Jason Terrell Resigned 2022-11-25
Mickie Henshall Appointed 2022-08-16
Key facts CIK 93314 CUSIP 928661206 13F (30d) 26 filings 25 filers Visit website Investor relations